Africa may have reached the pandemic's holy grail
New findings from Malawi suggest the country has entered something akin to the endemic stage of the pandemic — along with many other African nations.
When the results of his study came in, Kondwani Jambo was stunned.
He's an immunologist in Malawi. And last year he had set out to determine just how many people in his country had been infected with the coronavirus since the pandemic began.
Jambo, who works for the Malawi-Liverpool-Wellcome Trust Clinical Research Programme, knew the total number of cases was going to be higher than the official numbers. But his study revealed that the scale of spread was beyond anything he had anticipated — with a huge majority of Malawians infected long before the omicron variant emerged. "I was very shocked," he says.
Most important, he says, the finding suggests that it has now been months since Malawi entered something akin to what many countries still struggling with massive omicron waves consider the holy grail: the endemic stage of the pandemic, in which the coronavirus becomes a more predictable seasonal bug like the flu or common cold.
In fact, top scientists in Africa say Malawi is just one of many countries on the continent that appear to have already reached — if not quite endemicity — at least a substantially less threatening stage, as evidenced by both studies of the population's prior exposure to the coronavirus and its experience with the omicron variant.
The Malawi mystery
To understand how these scientists have come to hold this view, it helps to first consider what the pandemic has looked like in a country such as Malawi.
Before the omicron wave, Malawi didn't seem to have been hit too hard by COVID-19. Even by July of last year, when Malawi had already gone through several waves of the coronavirus, Jambo says it appeared that only a tiny share of Malawians had been infected.
"Probably less than 10% [of the population], if we look at the number of individuals that have tested positive," says Jambo.
The number of people turning up in hospitals was also quite low — even during the peak of each successive COVID-19 wave in Malawi.
Jambo knew this likely masked what had really been going on in Malawi. The country's population is very young — it has a median age of around 18, he notes. This suggests most infections prior to omicron's arrival were probably asymptomatic ones unlikely to show up in official tallies. People wouldn't have felt sick enough to go to the hospital. And coronavirus tests were in short supply in the country and therefore were generally used only for people with severe symptoms or who needed tests for travel.
So to fill in the true picture, Jambo and his collaborators turned to another potential source of information: a repository of blood samples that had been collected from Malawians month after month by the national blood bank. And they checked how many of those samples had antibodies for the coronavirus. Their finding: By the start of Malawi's third COVID-19 wave with the delta variant last summer, as much as 80% of the population had already been infected with some strain of the coronavirus.
"There was absolutely no way we would have guessed that this thing had spread that much," says Jambo.
Similar studies have been done in other African countries, including Kenya, Madagascar and South Africa, adds Jambo. "And practically in every place they've done this, the results are exactly the same" — very high prevalence of infection detected well before the arrival of the omicron variant.
Jambo thinks the findings from the blood samples in Malawi explain a key feature of the recent omicron wave there: The number of deaths this time has been a fraction of the already low number during previous waves.
Less than 5% of Malawians have been fully vaccinated. So Jambo says their apparent resistance to severe disease was likely built up as a result of all the prior exposure to earlier variants.
"Now we have had the beta variant — we have had the delta variant and the original," notes Jambo. "It seems like a combination of those three has been able to neutralize this omicron variant in terms of severe disease."
A promising pattern
And now that the omicron wave has peaked across Africa, country after country there seems to have experienced the same pattern: a huge rise in infections that has not been matched by a commensurate spike in hospitalizations and death.
Shabir Madhi is a prominent vaccinologist at the University of the Witwatersrand in South Africa.
"I think we should draw comfort from the fact that this has been the least severe wave in the country," he says.
The most likely reason, he says, is that — like Malawi — South Africa gained immunity through prior infections, he says.
One difference is that in South Africa's case, this immunity came at a high price. South Africa's population is substantially older than Malawi's, and during the delta wave last summer, hospitals in the country were swamped.
Still, the upshot, says Mahdi, is that "we've come to a point where at least three-quarters — and now after omicron, probably 80% — of South Africans have developed immunity and at least protection against severe disease and death."
Will the protection last?
Of course, whether Africa is truly now in a less dangerous position depends on a "key question," says Emory University biologist Rustom Antia. "How long does the immunity that protects us from getting ill last?" Antia has been studying what would need to happen for the coronavirus to become endemic.
But Mahdi says there's reason to be optimistic on this front. Research suggests this type of protection could last at least a year. So Mahdi says in African countries — and likely in many other low- and middle-income countries with similar experiences of COVID-19 — the takeaway is already clear: "I think we've reached a turning point in this pandemic. What we need to do is learn to live with the virus and get back to as much of a normal society as possible."
What does that look like? For one thing, says Mahdi, "we should stop chasing just getting an increase in the number of doses of vaccines that are administered." Vaccination efforts should be more tightly targeted on the vulnerable: "We need to ensure that at least 90% of people above the age of 50 are vaccinated."
Similarly, when the next variant comes along, Mahdi says, it will be important not to immediately panic over the mere rise in infections. This rise will be inevitable, and any policy that's intended to stop it with economically disruptive restrictions, such as harsh COVID-19 lockdowns, isn't just unnecessarily damaging — "it's fanciful thinking." Instead, officials should keep an eye out for the far more unlikely scenario of a rise in severe illness and death.
Copyright 2022 NPR. To see more, visit https://www.npr.org.